Biblio

21 Ergebnisse exportiert:
Autor Titel [ Typ(Desc)] Jahr
Filterkriterien: Anfangsbuchstabe Des Nachnamens is M  [Alle Filter deaktivieren]
Conference Paper
Jussila L, Veikkola T, Jeltsch M, Thurston G, McDonald D, Achen M, u. a.. Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice. In Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. Miami Beach, Florida; 2001. PDF Icon Jussila et al., 2001 (279.47 KB)
Journal Article
Saharinen P, Helotera H, Miettinen J, Norrmen C, D'Amico G, Jeltsch M, u. a.. Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development. Genes Dev [Internet]. 2010;24(9):875 - 80. http://view.ncbi.nlm.nih.gov/pubmed/20439428PDF Icon Pipsa Saharinen et al., Genes & Development 2010 (1.2 MB)PDF Icon Pipsa Saharinen et al., Genes & Development 2010, supplement (9.15 MB)
Tammela T, He Y, Lyytikkä J, Jeltsch M, Markkanen J, Pajusola K, u. a.. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins. Circ Res [Internet]. 2007;100(10):1468 - 75. http://view.ncbi.nlm.nih.gov/pubmed/17478733PDF Icon Tuomas Tammela et al., Circulation Research 2007 (1.1 MB)
Keskitalo S, Tammela T, Lyytikka J, Karpanen T, Jeltsch M, Markkanen J, u. a.. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein. Circ Res [Internet]. 2007;100(10):1460 - 7. http://view.ncbi.nlm.nih.gov/pubmed/17478734PDF Icon Salla Keskitalo et al., Circulation Research 2007 (1.98 MB)
Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, u. a.. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (80- ) [Internet]. 1997;276(5317):1423 - 5. http://view.ncbi.nlm.nih.gov/pubmed/9162011PDF Icon Michael Jeltsch et al., Science 1997 (293.65 KB)
Hiltunen MO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, Rissanen TT, u. a.. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation [Internet]. 2000;102(18):2262 - 8. http://view.ncbi.nlm.nih.gov/pubmed/11056103PDF Icon Mikko Hiltunen et al., Circulation 2000 (1.44 MB)
Veikkola T, Lohela M, Ikenberg K, Mäkinen T, Korff T, Saaristo A, u. a.. Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function. FASEB J [Internet]. 2003;17(14):2006 - 13. http://view.ncbi.nlm.nih.gov/pubmed/14597670PDF Icon Tanja Veikkola et al., FASEB Journal 2006 (598.77 KB)
Karpanen T, Bry M, Ollila HM, Seppänen-Laakso T, Liimatta E, Leskinen H, u. a.. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ Res [Internet]. 2008;103(9):1018 - 26. http://view.ncbi.nlm.nih.gov/pubmed/18757827PDF Icon Terhi Kärpänen et al., Circulation Research 2008 (898.27 KB)PDF Icon Terhi Kärpänen et al., Circulation Research 2008, supplement (1.56 MB)
Karpanen T, Bry M, Ollila HM, Seppänen-Laakso T, Liimatta E, Leskinen H, u. a.. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ Res [Internet]. 2008;103(9):1018 - 26. http://view.ncbi.nlm.nih.gov/pubmed/18757827PDF Icon Terhi Kärpänen et al., Circulation Research 2008 (898.27 KB)PDF Icon Terhi Kärpänen et al., Circulation Research 2008, supplement (1.56 MB)
Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, u. a.. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest [Internet]. 2005;115(2):247 - 57. http://view.ncbi.nlm.nih.gov/pubmed/15668734PDF Icon Peter Baluk et al., Journal of Clinical Investigation 2005 (1.89 MB)
Li X, Tjwa M, Van Hove I, Enholm B, Neven E, Paavonen K, u. a.. Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arterioscler Thromb Vasc Biol [Internet]. 2008;28(9):1614 - 20. http://view.ncbi.nlm.nih.gov/pubmed/18511699PDF Icon Xuri Li et al., Arteriosclerosis, Thrombosis, and Vascular Biology 2008 (738.26 KB)PDF Icon Xuri Li et al., Arteriosclerosis, Thrombosis, and Vascular Biology 2008, data supplement (1012.6 KB)
Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, u. a.. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J [Internet]. 2001;20(6):1223 - 31. http://view.ncbi.nlm.nih.gov/pubmed/11250889PDF Icon Tanja Veikkola et al., EMBO Journal 2001 (491.14 KB)
Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, u. a.. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J [Internet]. 2001;20(6):1223 - 31. http://view.ncbi.nlm.nih.gov/pubmed/11250889PDF Icon Tanja Veikkola et al., EMBO Journal 2001 (491.14 KB)
Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, u. a.. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci U S A [Internet]. 1998;95(20):11709 - 14. http://view.ncbi.nlm.nih.gov/pubmed/9751730PDF Icon Birgitta Olofsson et al., PNAS 1998 (470.59 KB)
Achen MG, Jeltsch M, Kukk E, Mäkinen T, Vitali A, Wilks AF, u. a.. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A [Internet]. 1998;95(2):548 - 53. http://view.ncbi.nlm.nih.gov/pubmed/9435229PDF Icon Marc Achen et al., PNAS 1998 (447.59 KB)
Pepper MS, Mandriota SJ, Jeltsch M, Kumar V, Alitalo K. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J Cell Physiol [Internet]. 1998;177(3):439 - 52. http://view.ncbi.nlm.nih.gov/pubmed/9808152PDF Icon Michael Pepper et al., Journal of Cellular Physiology 1998 (689.97 KB)
Bry M, Kivelä R, Holopainen T, Anisimov A, Tammela T, Soronen J, u. a.. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation [Internet]. 2010;122(17):1725 - 33. http://view.ncbi.nlm.nih.gov/pubmed/20937974PDF Icon Maija Bry et al., Circulation 2010 (2.23 MB)PDF Icon Maija Bry et al., Circulation 2010, supplement (17.77 MB)
Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, u. a.. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J [Internet]. 2001;20(4):672 - 82. http://view.ncbi.nlm.nih.gov/pubmed/11179212PDF Icon Stefano Mandriota et al., EMBO Journal 2001 (736.96 KB)
Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, u. a.. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J [Internet]. 2001;20(4):672 - 82. http://view.ncbi.nlm.nih.gov/pubmed/11179212PDF Icon Stefano Mandriota et al., EMBO Journal 2001 (736.96 KB)
Oh SJ, Jeltsch MM, Birkenhäger R, McCarthy JE, Weich HA, Christ B, u. a.. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol [Internet]. 1997;188(1):96 - 109. http://view.ncbi.nlm.nih.gov/pubmed/9245515PDF Icon Su-Ja Oh et al., Developmental Biology 1997 (3.28 MB)
Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, u. a.. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol [Internet]. 2003;161(6):1163 - 77. http://view.ncbi.nlm.nih.gov/pubmed/12810700PDF Icon Holger Gerhardt et al., The Journal of Biological Chemistry 2003 (2.24 MB)